View Larger
Ronald W. Davis
Academic Appointments
- Professor, Biochemistry
- Member, Bio-X
- Member, Stanford Cancer Institute
- Professor, Genetics
Key Documents
Contact Information
- Academic Offices
Personal Information Email Tel (650) 812-2021
Professional Overview
Honors and Awards
- Gruber Genetics Prize, Gruber Foundation (2011)
- Inventor of the Year, SVIPLA (2011)
- Distinguished Alumni Award, California Institute of Technology (2007)
- Recipient of, Dickson Prize in Medicine, University of Pittsburgh (2005-2004)
- Lifetime Achievement Award, Genetics Society of America (2004)
- Herbert A. Sober Award, ASBMB/IUBMB (2004)
Postdoctoral Advisees
Michael Akhras, Saharnaz Bigdeli, Colin Harvey, Billy Lau, Janine Mok, Kee-Hyun Paik, Soyoung Ryu, Junhee Seok, Judith Zaugg
Internet Links
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industrial and other commercial partners. It is our policy to disclose payments (exclusive of travel support) from, and/or equity in, companies or other commercial entities to Stanford faculty of $5,000 or more in total value, as well as any equity in a privately held company, when the faculty member also has institutional responsibilities related to his or her interactions with the company. View Full Information
Scientific Focus
Current Research Interests
We are using Saccharomyces cerevisiae and Human to conduct whole genome analysis projects. The yeast genome sequence has approximately 6,000 genes. We have made a set of haploid and diploid strains (21,000) containing a complete deletion of each gene. In order to facilitate whole genome analysis each deletion is molecularly tagged with a unique 20-mer DNA sequence. This sequence acts as a molecular bar code and makes it easy to identify the presence of each deletion. The mixture of all such tag strains then allows for the analysis of the entire genome with the manipulation of a single culture. During growth under a variety of conditions the loss of a tag indicates the loss of a deletion from the population. The concentration of each tag is determined by PCR amplification of the tags and hybridization to an Affymetrix DNA chip that contains the complement to all of the DNA sequence tags. This approach is being applied to other microorganisms.
We have identified a number of wild isolates of yeast that grow at much higher temperatures than is typical for Saccharomyces cerevisiae and are pathogenic and can kill a mouse. Microarrays have been used to map complex genetic traits such as virulence traits in pathogenic Saccharomyces cerevisiae using hybridization to detect single nucleotide polymorphisms. We have developed a new technology termed Recipical Hemizygosity Scanning that allows the determination of the contribution to the phenotype of all pair wise alleles for the whole genome from 2 independent strains. Using this technology we can map and quantitate all of the alleles in the genome for any complex quantitative trait in a single tube assay. These technologies will allow us to explore allelic contributions in complex mixed culture real environments and to investigate ecology at the genome level.
We are conducting a whole genome analysis (transcriptome and proteome) from blood of Human trauma patients. In this large clinical study we are establishing the standards for clinical genomics. We have developed 2 new technologies, "Molecular Inversion Probes" (MIP) for massive multiplex analysis of SNP and DNA content in Human and, "Mismatch Repair Detection" for discovery of rare Human polymorphisms. Both technologies are being applied to numerous clinical investigations.
Publications
- Classification of patients from time-course gene expression. Biostatistics. 2013; (1): 87-98
- Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A. 2013; (9): 3507-12
- Microneedle Biosensor: A Method for Direct Label-free Real Time Protein Detection. Sens Actuators B Chem. 2013: 848-855
- A peripheral blood diagnostic test for acute rejection in renal transplantation. Am J Transplant. 2012; (10): 2710-8
- A rapid, cost-effective method of assembly and purification of synthetic DNA probes >100 bp. PLoS One. 2012; (4): e34373
- Cationic amphiphilic drugs are potent inhibitors of yeast sporulation. PLoS One. 2012; (8): e42853
Help